“Evaluation of CD4+, CD39+, FOXP3+Tregulatory cells in Iraqi Alopecia areata patients by ELISA” (2022) Journal of Pharmaceutical Negative Results, 13, pp. 247–250. doi:10.47750/pnr.2022.13.S05.32.